Researchers found that miR-185-3p overexpression enhanced the chemical sensitivity of drug-resistant colorectal cancer (CRC) cells through inhibiting AQP5, offering potential therapeutic targets for CRC cells that are resistant to 5-FU (Zhou et al., 2020). Here, AQP5 is linked to colorectal carcinoma.